Research progress in the role of inflammatory factors in the pathogenesis of pre-diabetes
ZUO Jiaojiao1 WANG Xiaoxia1 ZHANG Dinghua2 SHI Xiaowei2 QIU Lianli3
1.Clinical College of Chinese Medicine, Gansu University of Chinese Medicine, Gansu Province, Lanzhou 730030，China;
2.Department of Endocrinology, Gansu Provincial Hospital of TCM, Gansu Province, Lanzhou 730030, China;
3.Department of Acupuncture, Gansu Provincial Hospital of TCM, Gansu Province, Lanzhou 730050, China
Abstract：The prevalence of type 2 diabetes and pre-diabetes is increasing year by year. Early detection of risk factors for pre-diabetes and timely diagnosis and intervention to prevent and reduce the occurrence and development of diabetes and its complications are worthy of attention and research. The role of inflammatory factors in the development of pre-diabetes has been one of the research hotspots in the field of endocrine metabolism. CRP, TNF-α, IL-6 and other novel inflammatory factors has also been discovered by more and more researchers. In this paper，the research progress of the role of inflammatory factors in the pathogenesis of pre-diabetes in recent years is reviewed in order to provide new ideas for the intervention of pre-diabetes.
左娇娇1 王晓霞1 张定华2 史晓伟2 邱连利3. 炎症因子在糖尿病前期发病中的作用研究进展[J]. 中国医药导报, 2020, 17(3): 38-40,44.
ZUO Jiaojiao1 WANG Xiaoxia1 ZHANG Dinghua2 SHI Xiaowei2 QIU Lianli3. Research progress in the role of inflammatory factors in the pathogenesis of pre-diabetes. 中国医药导报, 2020, 17(3): 38-40,44.
[1] 中国2型糖尿病防治指南（2017年版）[J].中国实用内科杂志，2018，38（4）：292-344.
[2] International Diabetes Federation. IDF diabetes atlas [M]. 8th ed. Brussels：Int. Diabetes Fed，2017，32-34.
[3] IDF Diabetes Atlas Group. Update of mortality attributable to diabetes for the IDF diabetes atlas：estimates for the year 2013 [J]. Diabetes Res Clin Pract，2015，109（3）：461-465.
[4] Wang L，Gao P，Zhang M，et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013 [J]. JAMA，2017，317（24）：2515-2523．
[5] Forouhi NG，Luan J，Hennings S，et al. Incidence of type 2 diabetes in England and its association with baseline impaired fasting glucose：the Ely study 1990-2000 [J]. Diabetic Med，2007，24（2）：200.
[6] Shoelson SE，Lee J，Goldfine AB. Inflammation and insulin resistance [J]. J Clin Invest，2006，116（7）：1793-1801.
[7] Wang X，Gao H，Xu H. Cluster Analysis of Unhealthy Lifestyles among Elderly Adults with Prediabetes： A Cross-Sectional Study in Rural China [J]. Diabetes Ther，2019，10（5）：1935-1948.
[8] 董茜妍，赵跃萍，梁园园，等.阿格列汀联合二甲双胍对糖耐量减低患者血浆C-反应蛋白和血脂水平的影响[J].海南医学，2015，26（24）：3601-3604.
[9] Pickup JC，Mattock MB，Chusney GD，et al. NIDDM as a disease of the innate immune system：association of acute-phase reactants and interleukin-6 with metabolic syndrome X [J]. Diabetologia，1997，40（11）：1286-1292.
[10] 陈涛，石秀娥，王一萍，等.糖耐量异常人群血清hs-CRP、Hcy、CysC水平与颈动脉粥样硬化的相关性研究[J].国际检验医学杂志，2018，39（15）：1838-1841.
[11] Kato K，Otsuka T，Saiki Y，et al. Elevated C-reactive Protein Levels Independently Predict the Development of Prediabetes Markers in Subjects with Normal Glucose Regulation [J]. Exp Clin Endocrinol Diabetes，2019，127：1-7.
[12] Celeste P.Durnwald，Katheryne Downes，et al. Predicting persistent impaired glucose tolerance in patients with gestational diabetes：The role of high sensitivity CRP and adiponectin [J]. Diabetes/Metab Rev，2018，34（2）：e2 958.
[13] 谈力欣，刘焱，张秀云，等.2型糖尿病合并非酒精性脂肪肝患者炎性因子、氧化应激、硫氧还蛋白互作蛋白水平研究及相关性分析[J].河北医药，2018，40（9）：1285-1289.
[14] Pradhan AD，Manson JE，Rifai N，et al. C-reactive protein interleukin-6，and risk of developing type 2 diabetes mellitus [J] .JAMA，2001，286（3）：327-334.
[15] 周咏梅，舒燕.原发性高血压合并非糖尿病患者血浆肿瘤坏死因子-α水平变化与胰岛素抵抗的关系[J].实用医院临床杂志，2018，15（5）：76-78.
[16] Son M，Wu J. Egg white hydrolysate and peptide reverse insulin resistance associated with tumor necrosis factor-α （TNF-α） stimulated mitogen-activated protein kinase （MAPK） pathway in skeletal muscle cells [J]. Eur J Nutr，2019，58（5）：1961-1969.
[17] DuPont JJ，Jaffe IZ. 30 years of the mineralocorticoid receptor：The role of the mineralocorticoid receptor in the vasculature [J]. Endocrinol，2017，234（1）：T67-T82.
[18] 陈晨，朱千里，叶渤之，等.高血压合并糖尿病前期炎症因子TNF-α和IL-6水平的研究[J].心电与循环，2016， 35（3）：170-173，180.
[19] Saukkonen T，Mutt SJ，Jokelainen J，et al. Adipokines and inflammatory markers in elderly subjects with high risk of type 2 diabetes and cardiovascular disease [J]. Sci Rep，2018，8（1）：12 816.
[20] 陈凯庭，郝亚楠，董学勤，等.不同糖耐量人群血清肿瘤坏死因子-α、游离脂肪酸、脂联素水平变化及其相关因素分析[J].疑难病杂志，2017，16（6）：592-595.
[21] Bacha F，Saad R，Gungor N，et al. Adiponnectin in youth：relationship to visceral adiposity，insulin sensitivity，and beta cell function [J]. Diabetes Care，2004，27（2）：547-552.
[22] Senn JJ，Klover PJ，Nowak IA，et al. Interleukin-6 induces cellular insulin resistance in hepatocytes [J]. Diabetes，2002，51（12）：3391-3399.
[23] Salmerón D，Gómez García F，Pons-Fuster E，et al. Screening for prediabetes and risk of periodontal disease [J]. Dev Program Diabetes Metab Syndr，2019，13（2）：1661-1666.
[24] Chiu HC，Fu MM，Yang TS，et al. Effect of high glucose，Porphyromonas gingivalis lipopolysaccharide and advanced glycation end-products on production of interleukin-6/-8 by gingival fibroblasts [J]. J Periodont Res，2017，52：268-276.
[25] 陈招进.糖尿病患者血清APN、Hcy与IL-6水平检测及临床意义[J].实用医药杂志，2016，33（6）：490-492.
[26] 熊智敏.糖尿病患者血清脂联素与白介素-6水平检测及临床意义[J].临床医药实践，2017，26（7）：526-528.
[27] 王科峰，柴林燕，张允东，等.DPP-4抑制剂联合二甲双胍对2型糖尿病患者血糖控制、氧化应激及炎症反应的影响[J].海南医学院学报，2018，24（4）：492-495， 499.
[28] 刘敏.血清白介素6与糖尿病肾病的相关性研究[J].实用糖尿病杂志，2018，14（1）：56-57.
[29] Brahimaj A，Ligthart S，Ghanbari M，et al. Novel inflammatory markers for incident pre-diabetes and type 2diabetes： the Rotterdam Study [J]. Eur J Epidemiol，2017， 32（3）：217-226.
[30] Di Pino A，Currenti W，Urbano F，et al. Low advanced glycation end product diet improves the lipid and inflflammatory profifiles of prediabetic subjects [J]. Clin Lipidol，2016，10（5）：1098-1108.
[31] Alfaqih MA，Al-Mughales F，Al-Shboul O，et al. Association of Adiponectin and rs1 501 299 of the ADIPOQ Gene with Prediabetes inJordan [J]. Biomolecules，2018， 8（4）：E117.
2020, Vol. 17 
京公网安备 11010502046598号